October 27, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG Oncology Winter 2026 Travel Awards - Deadline Approaching

NRG Oncology seeks to support robust participation in our semiannual meetings through the provision of travel support.

The application deadline is October 31, 2025 at 11:59 PM ET. Awardees will be notified by November 14, 2025. More information



Reminder, the following clinical trials are open to enrollment. Please continue to review your patient population and discuss enrollment opportunities with your clinical teams. All protocol related documents are posted on CTSU.

NRG-BR009/OFSET is a Phase III randomized trial now enrolling premenopausal women with pN0-1, ER-positive and HER2-negative breast cancer.

NRG-GY026 is now accruing patients of all stages and all histologic subtypes of endometrial cancer.

NRG-HN010: The HER2-positive cohort remains open and actively recruiting patients with salivary gland cancer.

NRG-LU007 is enrolling patients with extensive stage small-cell lung cancer. Only 17 more patients to complete the phase II portion of this trial!

ACTIVATION

HEAD & NECK

NRG-HN006: Reopened to Phase III. See Study Memorandum dated October 22, 2025 (posted on CTSU)

TERMINATION

GYNECOLOGIC

NRG-GY017: Terminated September 12, 2025; version date: November 8, 2018 (posted on NRG Oncology)

CLOSURE

BRAIN

NRG-BN012: Study Closure Memorandum dated October 21, 2025 (posted on CTSU)

AMENDMENT

BRAIN

NRG-BN011: Amendment 4, version date October 3, 2025 (posted on CTSU)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only. Read More

2. BIOSPECIMEN BANK

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

Kit Shipments to Sites in Canada

Important information re: shipments of kits from BB Columbus to Sites in Canada. Please see the memorandum, dated August 18, 2025, posted on CTSU.

3. BRAIN

NRG-BN011: Beginning September 12, 2025, please use the updated NRG-BN011 Gleostine® (lomustine) Clinical Trial Order form (posted on CTSU). The prescription form is no longer required and PHI should not be sent to Azurity. An updated memo is also posted on CTSU. Please update pharmacy staff as well.

4. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: Clinical research professionals can sign up for NRG Oncology Weekly Broadcasts to receive monthly FORTE Fridays updates directly to your inbox (click here).

5. GASTROINTESTINAL

NRG-GI012: The following documents are available on the CTSU website:

• Spanish-translated consent form and CIRB approval of the form;
• CIRB approval of Participant Brochure and Patient Study Web Page, version date October 6, 2025;
• Training Slides, version date October 14, 2025;
• Updated Biospecimen Collection and Submission Manual, version date October 10, 2025.

6. GYNECOLOGIC

NRG-GY020: Approaching its final analysis. To provide the investigators with the most accurate information, please submit all overdue data and update any outstanding patient data queries by December 1, 2025.

NRG-GY031: Please note there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

NRG-GY037 requires blocks to be submitted, but the study team recognizes variations in site operating procedures to release blocks. Please refer to the Letter to Pathologists in the Biospecimen Collection and Submission Manual. If your site is experiencing any issues with this requirement, please contact the study team as we can work with sites on a case-by-case basis to ensure patients have an opportunity to participate in this trial.

7. HEAD & NECK

NRG-HN008: Reminder: Please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

NRG-HN014: An updated Biospecimen Collection and Submission Manual, version date October 22, 2025, is available on CTSU.

8. VTOC TRAINING

For all NRG studies that use VTOC (Vision Tree Optimal Care): It has come to our attention that although Vision Tree has whitelisted their domain, Yahoo and AT&T have strong filters for spam that have been prohibiting participants from getting their emails. Please ask participants to 1) save the email address (fasttrack@optimalcare.com) as a contact or 2) suggest an alternative email (i.e. gmail is a successful alternative) when setting up their accounts.



The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-BN014, NRG-BR009, NRG-CC005, NRG-CC011, NRG-CC013, NRG-CC014, NRG-CC015, NRG-GI011, NRG-GI012, NRG-GU015, and NRG-HN014. Space is limited so register now and reserve your seat. The next webinar training is scheduled for November 12, 2025.

1. NRG Oncology Winter 2026 Travel Awards

NRG Oncology seeks to support robust participation in our semiannual meetings through the provision of travel support. Current priorities for travel awards include young investigators, study chairs and engaged study champions, active committee members, member institution PI’s, and clinical research professionals who are actively engaged with NRG Oncology committees. Our partnering foundations, RTOG Foundation, NSABP Foundation, and GOG Foundation may also consider supporting requests through this mechanism.

The application deadline is October 31, 2025 at 11:59 PM ET. Awardees will be notified by November 14, 2025. More information | Apply for NRG Travel Award 

5. NRG Oncology Current Committee Leadership Openings

• Chair, Medical Physics Subcommittee
  Applications DUE October 31, 2025 - Read more & How to Apply

• Chair, Medical Oncology Committee
  Applications DUE October 31, 2025 - Read more & How to Apply

6. NRG Member Information Form

We are excited to introduce the NRG Member Information Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

PUBLICATIONS REMINDERS

Publications Policy & Guidelines

Please review the NRG Oncology Publications Policy & Guidelines for guidance on publication requirements.

Author Contact Information

All Authors are advised to keep their contact information up to date either via the NCI Clinical Trials Support Unit (CTSU) portal (https://ctsu.cancer.gov/) or by notifying NRG-Publications@NRGOncology.org directly.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; Oct 22-26, 2025; Boston, MA

American Society of Clinical Oncology (ASCO) GI; Jan 8-10, 2026; San Francisco, CA

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2025; Cape Town, South Africa

Radiological Society of North America (RSNA); Nov 30-Dec 4, 2025; Chicago, IL

San Antonio Breast Cancer Symposium (SABCS); Dec 9-12, 2025; San Antonio, TX

Society for Neuro-Oncology (SNO); Nov 19-23, 2025; Honolulu, HI

Society for Immunotherapy of Cancer (SITC); Nov 5-9, 2025; National Harbor, MD

Society of Surgical Oncology (SSO) – Advanced Cancer Therapies; Feb 14-16, 2026; Fort Lauderdale, FL

Society of Urologic Oncology (SUO); Dec 2-5, 2025; Dallas, TX

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association for Cancer Research (AACR); Apr 17-22, 2026; San Diego, CA; Due to publications committee Nov 4, 2025; Submission deadline Nov 18, 2025, 11:59 pm ET; LBA and Clinical Trials Jan 6, 2026, 11:59 pm ET

American Head & Neck Society (AHNS) Annual Meeting; Jul 18-22, 2026; Boston, MA; Due to publications committee Nov 21, 2025; Submission deadline Dec 5, 2025, 5:00 pm ET

American Radium Society (ARS) Annual Meeting; Apr 30-May 3, 2026; Newport Beach, CA; Submission deadline Nov 1, 2025, 11:59 pm ET

American Society of Breast Surgeons (ASBrS); Apr 29-May 3, 2026; Seattle, WA; Submission deadline Nov 6, 2025, 12:00 am PT; LBA Jan 9, 2026, 12:00 am PT

American Society of Clinical Oncology (ASCO); May 29-Jun 2, 2026; Chicago, IL; Due to publications committee Jan 13, 2026; Submission deadline Jan 27, 2026, 11:59 pm ET; LBA Mar 9, 2026, 12:00 pm ET (placeholder required)

American Society of Clinical Oncology (ASCO) GU; Feb 26-28, 2026; San Francisco, CA; LBA Nov 20, 2025, 12:00 pm ET (placeholder required)

American Society of Colon and Rectal Surgeons (ASCRS); May 9-12, 2026; Tampa, FL; LBA and Clinical Trials Jan 28, 2026

European Society of Gynaecological Oncology (ESGO); Feb 26-Mar 1, 2026; Copenhagen, Denmark; Submission deadline Oct 31, 2025, 23:59 CET; LBA Jan 15, 2026

American Society for Radiation Oncology (ASTRO); Boston, MA; Sep 27-30, 2026; Due to publications committee Feb 10, 2026; Submission deadline Feb 24, 2026; LBA Apr 20, 2026 (placeholder required)

ESMO (European Society for Medical Oncology) Breast; May 6-8, 2026; Berlin, Germany; Due to publications committee Jan 13, 2026; Submission deadline Jan 27, 2026, 21:00 CST; LBA Mar 31, 2026, 21:00 CST (placeholder required)

European Society for Radiotherapy and Oncology (ESTRO); May 15-19, 2026; Stockholm, Sweden; Due to publications committee Oct 29, 2025; Submission deadline Nov 12, 2025; LBA Apr 8, 2026

Miami Breast Cancer Conference; Mar 5-8, 2026; Miami, FL; Due to publications committee Dec 22, 2025; Submission deadline Jan 5, 2026, 5:00 pm ET

Society of Surgical Oncology (SSO) – Annual Meeting; Mar 5-7; Phoenix, AZ; LBA Dec 1, 2025, 11:59 pm CT